Lamepil 50 Tablet contains Lamotrigine 50mg, an antiepileptic medication primarily indicated for the treatment of epilepsy and bipolar disorder. Lamotrigine acts by stabilizing neuronal membranes through inhibition of voltage-sensitive sodium channels, thereby reducing the release of excitatory neurotransmitters such as glutamate. This mechanism helps to prevent the spread of seizure activity in the brain and stabilize mood fluctuations. Lamepil 50 is commonly prescribed for the management of partial seizures, generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome. Additionally, it is effective as a mood stabilizer in bipolar disorder, particularly in the prevention of depressive episodes. The medication is administered orally, with dosage individualized based on patient response and clinical condition. Initiation and titration should be gradual to minimize the risk of serious skin reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Common adverse effects may include dizziness, headache, blurred vision, nausea, and rash. Patients should be monitored closely during therapy, especially during dose escalation. Lamepil 50 should be used cautiously in patients with hepatic or renal impairment and is contraindicated in individuals with known hypersensitivity to Lamotrigine or any of its excipients.